Loading...
Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction
Examination of cross-protection and type replacement after human papillomavirus (HPV) vaccine introduction is essential to guide vaccination recommendations and policies. The aims of this study were to examine trends in non-vaccine-type HPV: 1) genetically related to vaccine types (to assess for cro...
Na minha lista:
| Udgivet i: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6746493/ https://ncbi.nlm.nih.gov/pubmed/30633598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1564438 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|